Unknown

Dataset Information

0

Inhibition of the Tcf/beta-catenin complex increases apoptosis and impairs adrenocortical tumor cell proliferation and adrenal steroidogenesis.


ABSTRACT: To date, there is no effective therapy for patients with advanced/metastatic adrenocortical cancer (ACC). The activation of the Wnt/beta-catenin signaling is frequent in ACC and this pathway is a promising therapeutic target.To investigate the effects of the inhibition of the Wnt/beta-catenin in ACC cells.Adrenal (NCI-H295 and Y1) and non-adrenal (HeLa) cell lines were treated with PNU-74654 (5-200 ?M) for 24-96 h to assess cell viability (MTS-based assay), apoptosis (Annexin V), expression/localization of beta-catenin (qPCR, immunofluorescence, immunocytochemistry and western blot), expression of beta-catenin target genes (qPCR and western blot), and adrenal steroidogenesis (radioimmunoassay, qPCR and western blot).In NCI-H295 cells, PNU-74654 significantly decreased cell proliferation 96 h after treatment, increased early and late apoptosis, decreased nuclear beta-catenin accumulation, impaired CTNNB1/beta-catenin expression and increased beta-catenin target genes 48 h after treatment. No effects were observed on HeLa cells. In NCI-H295 cells, PNU-74654 decreased cortisol, testosterone and androstenedione secretion 24 and 48 h after treatment. Additionally, in NCI-H295 cells, PNU-74654 decreased SF1 and CYP21A2 mRNA expression as well as the protein levels of STAR and aldosterone synthase 48 h after treatment. In Y1 cells, PNU-74654 impaired corticosterone secretion 24 h after treatment but did not decrease cell viability.Blocking the Tcf/beta-catenin complex inhibits the Wnt/beta-catenin signaling in adrenocortical tumor cells triggering increased apoptosis, decreased cell viability and impairment of adrenal steroidogenesis. These promising findings pave the way for further experiments inhibiting the Wnt/beta-catenin pathway in pre-clinical models of ACC. The inhibition of this pathway may become a promising adjuvant therapy for patients with ACC.

SUBMITTER: Leal LF 

PROVIDER: S-EPMC4767488 | biostudies-other | 2015 Dec

REPOSITORIES: biostudies-other

altmetric image

Publications

Inhibition of the Tcf/beta-catenin complex increases apoptosis and impairs adrenocortical tumor cell proliferation and adrenal steroidogenesis.

Leal Letícia F LF   Bueno Ana Carolina AC   Gomes Débora C DC   Abduch Rafael R   de Castro Margaret M   Antonini Sonir R SR  

Oncotarget 20151201 40


<h4>Background</h4>To date, there is no effective therapy for patients with advanced/metastatic adrenocortical cancer (ACC). The activation of the Wnt/beta-catenin signaling is frequent in ACC and this pathway is a promising therapeutic target.<h4>Aim</h4>To investigate the effects of the inhibition of the Wnt/beta-catenin in ACC cells.<h4>Methods</h4>Adrenal (NCI-H295 and Y1) and non-adrenal (HeLa) cell lines were treated with PNU-74654 (5-200 μM) for 24-96 h to assess cell viability (MTS-based  ...[more]

Similar Datasets

| S-EPMC7579427 | biostudies-literature
| S-EPMC3958737 | biostudies-literature
| S-EPMC3567123 | biostudies-literature
| S-EPMC6067656 | biostudies-literature
2020-05-19 | GSE150775 | GEO
| S-EPMC4893026 | biostudies-literature
| S-EPMC3302881 | biostudies-literature
| S-EPMC7211035 | biostudies-literature
| S-EPMC4014965 | biostudies-literature
| S-EPMC7515458 | biostudies-literature